TuesdayApr 10, 2018 1:11 pm

Earth Science Tech, Inc. (ETST) on Course to Complete White Paper Studies in 2019

ETST will investigate combination drugs that combine a mineral element with full spectrum cannabinoid industrial hemp oil; it anticipates completion of white paper studies in early 2019, with clinical trials to follow Goal is to produce both an OTC nutraceutical product and a cannabinoid companion generic drug to fight the epidemic of opioid dependency Foundations Wellness Center reports that two million Americans are now addicted to opioids Earth Science Tech, Inc. (OTC: ETST) has set 2019 as the crucial year when the company anticipates completion of white paper studies and the start of human clinical trials to investigate the synergies…

Continue Reading

TuesdayApr 10, 2018 12:25 pm

Pressure BioSciences Inc.’s (PBIO) New Products and Enhanced Sales Capabilities Drive Plans for Banner 2018

Record product sales growth reported for fourth quarter and full year 2017 Company has over 300 of its ultra-high pressure instruments in research labs worldwide 2017 revenue exceeded $2.2 million with just one field sales rep; company’s field sales force expanded to five with recent hires December 2017 acquisition of high pressure IP allows company to enter the biologics contract research services sector Newly-issued patents in Ultra Shear Technology (UST) address broad markets for stable, water-soluble nanoemulsions, including cannabinoids As scientific researchers who work with cellular material seek to uncover new potential for creating vaccines and drugs, counteracting harmful chemicals…

Continue Reading

TuesdayApr 10, 2018 10:43 am

Lexaria Bioscience’s (CSE: LXX) (OTCQX: LXRP) Growing Patent Portfolio Enables Commercialization, Defense of DehydraTECH

LXRP recently received a new U.S. patent allowance for ‘composition of matter’ related to its DehydraTECH™ platform’s delivery of cannabinoids; based on past experience, company expects formal granting of patent within 100 days Company filed new U.S. patent application for use of DehydraTECH to improve the speed of absorption of active pharmaceutical ingredients through the skin; compared to other commercial formulations, LXRP product exhibited up to a 225 percent increase in permeability LXRP gets primary revenue through third party licensing fees related to its proprietary and patented intellectual property; goal is to partner with leading firms globally to deliver best-in-class…

Continue Reading

FridayApr 06, 2018 2:00 pm

Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) Extracts Maximum Benefit from Cannabis Portfolio

Forecasts predict $55.8 billion valuation for medical cannabis market by 2025 Pivot Pharmaceuticals building portfolio of diverse tech for improving bioavailability of cannabinoid therapies Company’s leadership team builds on decades of experience in pharmaceutical arena For nutrition-conscious consumers, scanning food product labels is a requisite part of any trip to the grocery store, but a recent study by the U.S. Department of Agriculture’s Agricultural Research Service (http://cnw.fm/i21Ex) found that the old maxim ‘what you see isn’t always what you get’ holds true when it comes to certain foods like nuts. Even though pistachios, for example, may have 161.9 calories per ounce,…

Continue Reading

FridayApr 06, 2018 12:48 pm

Strong Leadership Team Guides EVIO, Inc. (EVIO) toward 2018 Goal of Reaching 18 Total Cannabis Testing Labs

EVIO is a leading provider of cannabis analysis and testing in the U.S. Company on track to reach 18 labs by year-end 2018 Company is guided by strong team of industry and business experts Operating in one the hottest industries in the marketplace right now, EVIO, Inc. (OTCQB: EVIO) is a life sciences company leading the charge in cannabis analysis and testing. The company currently operates several laboratories throughout the United States—with many more on the horizon—and is a leading provider of accredited cannabis testing, delivering top-quality analytical and consulting services for agricultural and biomedical industries, as well as performing…

Continue Reading

ThursdayApr 05, 2018 12:47 pm

Earth Science Tech, Inc. (ETST) Accelerates the Development and Commercialization of Products

Company announces its membership in Défi Montréal, Canada’s largest business acceleration program Partnership with Laboratories BNK Canada, Inc. allows ETST to commercialize its new testing services more quickly Strategic acquisition aimed at improving access to funding for development of treatments for various diseases Earth Science Tech, Inc. (OTC: ETST), a Florida-based biotechnology company that operates in the fields of hemp cannabinoids, nutraceuticals, pharmaceuticals and medical devices, is taking active measures to accelerate its development and growth. On March 22, 2018, ETST announced its membership in the 16th cohort of Défi Montréal, the largest innovative business acceleration program in Quebec. Martin…

Continue Reading

ThursdayApr 05, 2018 11:05 am

EVIO, Inc. (EVIO) Puts Cannabis Quality and Safety to the Test

EVIO lab test revenues related to cannabis products grew by 782 percent last year Cannabis testing weeds out impurities such as chemicals and fungi while also analyzing potency Amid news of acclaimed accreditation in Florida, company plans major nationwide expansion As the cannabis industry continues to quietly flourish in North America, EVIO, Inc. (OTCQB: EVIO) is providing laboratory testing to help consumers ensure that the plant products they are getting meet stringent standards of healthful quality. The company has gained renown for its services as it provides consulting and high-quality analysis of cannabis plants grown under state-legal programs throughout the…

Continue Reading

WednesdayApr 04, 2018 1:38 pm

Xanthic Biopharma Inc. Establishing a New Paradigm in Cannabinoid Delivery

Filed patents to protect company’s process and products Powderized cannabis products deliver precise CBD/THC dosing with superior cannabinoid solubility Signed strategic partnership and licensing agreement with Avitas CBD Water After thousands of years of human use, cannabis is now at the center of a new revolution. The medical efficacy of certain cannabinoids is now settled science, and numerous advanced therapeutic applications are currently in development. Recreational cannabis use has gained broad acceptance in multiple U.S. states and, in a few months, becomes legal across all of Canada. However, whether for medicinal or recreational purposes, there have been long-standing problems with…

Continue Reading

TuesdayApr 03, 2018 1:38 pm

ChineseInvestors.com, Inc. (CIIX) to Debut ‘Bitcoin Big Winner’ Program on Phoenix North America Chinese Channel

Reinforcing its focus on cryptocurrency and TV broadcasts, CIIX recently unveiled plans to broadcast a daily commentary titled ‘Bitcoin Big Winner’ on the Phoenix North America Chinese Channel CIIX broadcasts a live daily video show titled ’Bitcoin MultiMillionaire’ from the floor of the NYSE; company plans to explore cryptocurrency mining at datacenter near Seattle CIIX sponsored 2018 National Investment Bankers Association (“NIBA”) meeting in New York to meet with micro-cap and small-cap investors ChineseInvestors.com, Inc. (OTCQB: CIIX) is reaching the global Chinese-speaking community with regard to bitcoin — with TV broadcasts, an online site, an ATM in the lobby of…

Continue Reading

TuesdayApr 03, 2018 9:00 am

Infusion of Biotechnology Into Cannabis Market Leads to Booming Growth

CBDWire Editorial Coverage: The tremendous growth of the licensed cannabis market has naturally led to an increase in research in this area. A number of specialist biotech companies have emerged, creating innovative cannabinoid applications. Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) (LXRP Profile) has developed technology to improve the palatability and speed of absorption of cannabinoid therapeutics, leading to a range of licensed products and related patents. Plant biotechnology company 22nd Century Group, Inc. (NYSE American: XXII) is altering the level of active ingredients in both cannabis and tobacco, allowing new strains to be grown for medical and other purposes.…

Continue Reading

CBDWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 303.498.7722